Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
FGFR4 inhib
>>
Advenchen
>>
Phase 4
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
66
132
198
264
330
396
462
528
594
660
Focus V
(anlotinib) / Advenchen, Sino Biopharm